CompletedPHASE1, PHASE2NCT02999815
Intrathecal Tetanus Immunoglobulin to Treat Tetanus
Studying Tetanus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oxford University Clinical Research Unit, Vietnam
- Principal Investigator
- Minh Yen Lam, MD, MDOxford University Clinical Research Unit
- Intervention
- Human tetanus immunoglobulin(procedure)
- Enrollment
- 272 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2017 – 2020
Study locations (1)
- Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Collaborators
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02999815 on ClinicalTrials.govOther trials for Tetanus
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE1NCT07149454Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody InjectionLanzhou Institute of Biological Products Co., Ltd
- RECRUITINGNCT07107932A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryZhuhai Trinomab Pharmaceutical Co., Ltd.
- RECRUITINGPHASE3NCT06635798A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 InjectionGenrix (Shanghai) Biopharmaceutical Co., Ltd.